Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Sekiguchi; Yoshinori
Address:
Tokyo, JP
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
8030499 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocy October 4, 2011
It is intended to provide a drug which is efficacious against pathological conditions relating to arginine-vasopressin V1b receptor. More particularly speaking, it is intended to provide a drug which has a therapeutic or preventive effect on depression, anxiety, Alzheimer's disease,
7601734 Cyclic amine compound October 13, 2009
An object of the present invention is to provide a cyclic amine compound which has a potent inhibitory effect on the binding of .alpha.2C-adrenoceptor and is useful in preventing and treating disorders attributable to .alpha.2C-adrenoceptor.The above-described object is solved by the
7544690 MCH receptor antagonists June 9, 2009
The present invention relates to novel compounds of the formula (I) which act as MCH receptor antagonists. These compositions are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of obesity, obesity related disorders, anxiety, or depression.
7528124 1,3-dihydro-2H-indol-2-one derivative May 5, 2009
A 1,3-dihydro-2H-indol-2-one derivative expressed by Formula 1 (wherein R.sub.1 is a halogen atom, a C.sub.1 to C.sub.4 alkyl group, etc., and R.sub.2 is a hydrogen atom, a halogen atom, etc., or R.sub.2 is in the 6-position of the indol-2-one and R.sub.1 and R.sub.2 join together to
5952715 Chip type electronic part September 14, 1999
A chip type electronic part of the present invention includes tapered notches rising from the bottom of the body of a molding. With this configuration, the electronic part achieves a high volume efficiency and a great bonding strength to a circuit board after soldering.
5597921 Indolo[2,3-b]quinoxaline derivatives January 28, 1997
Indolo[2,3-b]quinoxaline derivatives represented by the following formula: ##STR1## wherein one of R.sup.1 and R.sup.2 is a hydrogen atom and the other is a group of the formula:etc, and R.sup.3 is a hydrogen atom, a methyl group, etc.; and pharmaceutically acceptable salts thereof h
5576927 Electrolytic chip capacitor November 19, 1996
A solid electrolytic chip capacitor in which L-shaped portions of the anode terminal and cathode terminal form slanting surfaces which project beyond the projecting side surfaces of the resin sheathing.
5495046 Alkoxyphenylalkylamine derivatives February 27, 1996
An alkoxyphenylalkylamine derivative represented by the following formula: ##STR1## (wherein X.sup.1 and X.sup.2 may be either the same or different from each other and each represents a hydrogen atom, a halogen atom, a hydroxyl group, an alkoxy group having 1 to 5 carbon atoms or an










 
 
  Recently Added Patents
Location-based method to specify ratio frequency spectrum rights
Buffer pool extension for database server
Data processor with virtual machine management
Statistical identification of instances during reconciliation process
Crystal structure of human JAK3 kinase domain complex and binding pockets thereof
Generating package profiles in software package repositories using selective subsets of packages
Gangable electrical box and leveling assembly
  Randomly Featured Patents
Novel pyrrolidine-2-(1,3-dicarbonyl) derivatives, a process for their preparation, agents containing them, and their use
Watch
Profile for supporting panels
Serial bus interface for direct conversion receiver
Active on-patient sensor, method and system
IGBT with freewheeling diode
Supply air device
Electrical connecting device, and semiconductor device testing method
Tablet
Garden hand tool